Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phas... by Moreno, Carol, MD, Greil, Richard, Prof, Demirkan, Fatih, Prof, Tedeschi, Alessandra, MD, Anz, Bertrand, MD, Larratt, Loree, Prof, Simkovic, Martin, MD, Samoilova, Olga, MD, Novak, Jan, MD, Ben-Yehuda, Dina, Prof, Strugov, Vladimir, MD, Gill, Devinder, MD, Gribben, John G, Prof, Hsu, Emily, PhD, Lih, Chih-Jian, PhD, Zhou, Cathy, MS, Clow, Fong, ScD, James, Danelle F, MD, Styles, Lori, MD, Flinn, Ian W, MD

Get full text